IT IS A simple question. Do psychostimulants worsen tic disorders? In the 1970s and early 1980s, the answer was unequivocally yes. The presence of a tic disorder in a patient, or even a history of tics in a close family member, became a contraindication to prescribing methylphenidate hydrochloride.1 However, the answer has not remained simple. In this issue of the ARCHIVES, Gadow et al2 present their longitudinal follow-up of 29 children with attention-deficit/hyperactivity disorder (ADHD) and chronic multiple tic disorder (mostly Tourette syndrome) who were treated for 2 years with methylphenidate. They pose a public health question: "to address the issue of potential tic exacerbation from the standpoint of group data (ie, is treatment ill-advised in this clinic population?), and not to verify possible tic exacerbations in individual children." They conclude that treatment with methylphenidate does not result in long-term exacerbations of motor or vocal tics in prepubertal children, at least when their tics are mildly to moderately severe. This is an important, carefully designed study, which, in conjunction with the complementary reports on this topic in the past decade,3- 5 could lead to a more sophisticated understanding of the relationship between stimulants and tics.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Psychiatry editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 8
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.